Abstract: Preparations in powder form comprising or consisting of soluble or insoluble polyvinylpyrrolidone and/or polyvinylpyrrolidone copolymers and suitable as aid for pharmaceutical formulations comprise in homogeneous dispersion very small amounts of heavy metals which are physiologically tolerated in these amounts, or very small amounts of peroxide-cleaving enzymes.

Abstract: A cylindrical delayed release tablet with a convex or flat upper side and lower side is provided, along with a method for its production and a gelatin capsule containing 3-200 tablets of the same having identical or different release rates, wherein the tablet if made of .beta.-phenylpropiophenone derivatives of the formula I as active ingredient ##STR1## where R is n-propyl or 1,1-dimethylpropyl, and their pharmacologically acceptable salts, wherein the tablet has a height and diameter that are both, independently of one another, 1-3 mm, the active ingredient content is in the range from 81-99.

Abstract: A process for preparing a free-flowing redispersible powder composed of a vinyl-pyrrolidone/vinyl acetate copolymer containing 15-40% by weight of vinylpyrrolidone units wherein the mixture of the monomers is copolymerized in organic solution, the resulting solution is, after addition of a surfactant, subjected to replacement of the solvent by water, and the resulting dispersion is spray- or freeze-dried, and the use of the redispersible powder for producing paints and coating compositions, glues and adhesives and, in particular, the matrix and/or coating of solid slow-release pharma-ceutical forms and of hair-spray formulations are described.

Abstract: A mixture of an alginate and a polyacrylate in a ratio of from 15:1 to 1:2 is suitable for the preparation of depot drug forms.

Abstract: Riboflavin granules contain no inactive ingredient and have a mean particle diameter of from 50 to 1,000 .mu.m are produced as described and used for preparing drugs and human and animal foods.

Abstract: Ascorbic acid granules for direct tableting are prepared by the compacting method, wherein the ascorbic acid in the form of crystals or crystal fragments, of which not more than 40% by weight have a longest particle diameter of less than 50 .mu.m and not more than 15% by weight have a longest particle diameter greater than 500 .mu.m, and as a mixture with from 0.8 to 8% by weight of soluble polyvinylpyrrolidone having a water content of from 0.3 to 5% is compacted in a conventional manner, and the product is comminuted.